Thomas Hennessey
Director/Board Member presso AutoGenomics, Inc.
Relazioni attive
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Qiaobing Xu | M | - |
Hopewell Therapeutics, Inc.
 Hopewell Therapeutics, Inc. BiotechnologyHealth Technology Hopewell Therapeutics, Inc. is a company that is focused on discovering, synthesizing, and developing tissue-targeted lipid nanoparticles (TTLNPs) to bring genomic medicines to patients. The company is based in Woburn, MA and was founded in 2018 by Qiaobing Xu. Hopewell is pursuing opportunities to redefine the non-viral delivery space for novel genomic medicines by designing systemically administered LNPs to specifically target extrahepatic tissues and cells throughout the body. The company has built a robust intellectual property portfolio with an expansive library of ionizable lipids and has established partnerships with several industry-leading companies. Hopewell is developing its own internal pipeline, initially targeting diseases of the lung, while concurrently exploring the potential of its TTLNP platform for patients with unmet needs in oncology, infectious diseases, rare genetic diseases, and neurological disorders. Louis Brenner has been the CEO of the company since 2022. | 6 anni |
| Ramanath Vairavan | M | 76 |
AutoGenomics, Inc.
 AutoGenomics, Inc. Medical SpecialtiesHealth Technology AutoGenomics, Inc. engages in the design, development, manufacture, and marketing of an automated, microarray-based multiplexing diagnostic platform. The company was founded by Fareed Kureshy, Shailendra Singh, and Ramanath Vairavan in April 1999 and is headquartered in Carlsbad, CA. | 25 anni |
| Louis Brenner | M | 54 |
Hopewell Therapeutics, Inc.
Hopewell Therapeutics, Inc. BiotechnologyHealth Technology Hopewell Therapeutics, Inc. is a company that is focused on discovering, synthesizing, and developing tissue-targeted lipid nanoparticles (TTLNPs) to bring genomic medicines to patients. The company is based in Woburn, MA and was founded in 2018 by Qiaobing Xu. Hopewell is pursuing opportunities to redefine the non-viral delivery space for novel genomic medicines by designing systemically administered LNPs to specifically target extrahepatic tissues and cells throughout the body. The company has built a robust intellectual property portfolio with an expansive library of ionizable lipids and has established partnerships with several industry-leading companies. Hopewell is developing its own internal pipeline, initially targeting diseases of the lung, while concurrently exploring the potential of its TTLNP platform for patients with unmet needs in oncology, infectious diseases, rare genetic diseases, and neurological disorders. Louis Brenner has been the CEO of the company since 2022. | 2 anni |
| Keri J. Donaldson | M | - |
AutoGenomics, Inc.
AutoGenomics, Inc. Medical SpecialtiesHealth Technology AutoGenomics, Inc. engages in the design, development, manufacture, and marketing of an automated, microarray-based multiplexing diagnostic platform. The company was founded by Fareed Kureshy, Shailendra Singh, and Ramanath Vairavan in April 1999 and is headquartered in Carlsbad, CA. | - |
| Brian Eichenberger | M | - |
AutoGenomics, Inc.
AutoGenomics, Inc. Medical SpecialtiesHealth Technology AutoGenomics, Inc. engages in the design, development, manufacture, and marketing of an automated, microarray-based multiplexing diagnostic platform. The company was founded by Fareed Kureshy, Shailendra Singh, and Ramanath Vairavan in April 1999 and is headquartered in Carlsbad, CA. | - |
| James V. Canfield | M | 65 |
AutoGenomics, Inc.
AutoGenomics, Inc. Medical SpecialtiesHealth Technology AutoGenomics, Inc. engages in the design, development, manufacture, and marketing of an automated, microarray-based multiplexing diagnostic platform. The company was founded by Fareed Kureshy, Shailendra Singh, and Ramanath Vairavan in April 1999 and is headquartered in Carlsbad, CA. | 11 anni |
| Shailendra Singh | M | 85 |
AutoGenomics, Inc.
AutoGenomics, Inc. Medical SpecialtiesHealth Technology AutoGenomics, Inc. engages in the design, development, manufacture, and marketing of an automated, microarray-based multiplexing diagnostic platform. The company was founded by Fareed Kureshy, Shailendra Singh, and Ramanath Vairavan in April 1999 and is headquartered in Carlsbad, CA. | 25 anni |
| Howard Rosen | M | 66 |
Hopewell Therapeutics, Inc.
Hopewell Therapeutics, Inc. BiotechnologyHealth Technology Hopewell Therapeutics, Inc. is a company that is focused on discovering, synthesizing, and developing tissue-targeted lipid nanoparticles (TTLNPs) to bring genomic medicines to patients. The company is based in Woburn, MA and was founded in 2018 by Qiaobing Xu. Hopewell is pursuing opportunities to redefine the non-viral delivery space for novel genomic medicines by designing systemically administered LNPs to specifically target extrahepatic tissues and cells throughout the body. The company has built a robust intellectual property portfolio with an expansive library of ionizable lipids and has established partnerships with several industry-leading companies. Hopewell is developing its own internal pipeline, initially targeting diseases of the lung, while concurrently exploring the potential of its TTLNP platform for patients with unmet needs in oncology, infectious diseases, rare genetic diseases, and neurological disorders. Louis Brenner has been the CEO of the company since 2022. | - |
| Jake Xia | M | - |
Hopewell Therapeutics, Inc.
Hopewell Therapeutics, Inc. BiotechnologyHealth Technology Hopewell Therapeutics, Inc. is a company that is focused on discovering, synthesizing, and developing tissue-targeted lipid nanoparticles (TTLNPs) to bring genomic medicines to patients. The company is based in Woburn, MA and was founded in 2018 by Qiaobing Xu. Hopewell is pursuing opportunities to redefine the non-viral delivery space for novel genomic medicines by designing systemically administered LNPs to specifically target extrahepatic tissues and cells throughout the body. The company has built a robust intellectual property portfolio with an expansive library of ionizable lipids and has established partnerships with several industry-leading companies. Hopewell is developing its own internal pipeline, initially targeting diseases of the lung, while concurrently exploring the potential of its TTLNP platform for patients with unmet needs in oncology, infectious diseases, rare genetic diseases, and neurological disorders. Louis Brenner has been the CEO of the company since 2022. | - |
| Ted Xutian Jing | M | - |
Hopewell Therapeutics, Inc.
Hopewell Therapeutics, Inc. BiotechnologyHealth Technology Hopewell Therapeutics, Inc. is a company that is focused on discovering, synthesizing, and developing tissue-targeted lipid nanoparticles (TTLNPs) to bring genomic medicines to patients. The company is based in Woburn, MA and was founded in 2018 by Qiaobing Xu. Hopewell is pursuing opportunities to redefine the non-viral delivery space for novel genomic medicines by designing systemically administered LNPs to specifically target extrahepatic tissues and cells throughout the body. The company has built a robust intellectual property portfolio with an expansive library of ionizable lipids and has established partnerships with several industry-leading companies. Hopewell is developing its own internal pipeline, initially targeting diseases of the lung, while concurrently exploring the potential of its TTLNP platform for patients with unmet needs in oncology, infectious diseases, rare genetic diseases, and neurological disorders. Louis Brenner has been the CEO of the company since 2022. | - |
| Paige Onori | F | - |
AutoGenomics, Inc.
AutoGenomics, Inc. Medical SpecialtiesHealth Technology AutoGenomics, Inc. engages in the design, development, manufacture, and marketing of an automated, microarray-based multiplexing diagnostic platform. The company was founded by Fareed Kureshy, Shailendra Singh, and Ramanath Vairavan in April 1999 and is headquartered in Carlsbad, CA. | - |
| Mark Ibison | M | - |
AutoGenomics, Inc.
AutoGenomics, Inc. Medical SpecialtiesHealth Technology AutoGenomics, Inc. engages in the design, development, manufacture, and marketing of an automated, microarray-based multiplexing diagnostic platform. The company was founded by Fareed Kureshy, Shailendra Singh, and Ramanath Vairavan in April 1999 and is headquartered in Carlsbad, CA. | - |
| Peter Wilding | M | 89 |
AutoGenomics, Inc.
AutoGenomics, Inc. Medical SpecialtiesHealth Technology AutoGenomics, Inc. engages in the design, development, manufacture, and marketing of an automated, microarray-based multiplexing diagnostic platform. The company was founded by Fareed Kureshy, Shailendra Singh, and Ramanath Vairavan in April 1999 and is headquartered in Carlsbad, CA. | 12 anni |
| Kevin Stineman | M | - |
AutoGenomics, Inc.
AutoGenomics, Inc. Medical SpecialtiesHealth Technology AutoGenomics, Inc. engages in the design, development, manufacture, and marketing of an automated, microarray-based multiplexing diagnostic platform. The company was founded by Fareed Kureshy, Shailendra Singh, and Ramanath Vairavan in April 1999 and is headquartered in Carlsbad, CA. | - |
| Adam Levinson | M | 54 |
AutoGenomics, Inc.
AutoGenomics, Inc. Medical SpecialtiesHealth Technology AutoGenomics, Inc. engages in the design, development, manufacture, and marketing of an automated, microarray-based multiplexing diagnostic platform. The company was founded by Fareed Kureshy, Shailendra Singh, and Ramanath Vairavan in April 1999 and is headquartered in Carlsbad, CA. | 11 anni |
| Laurence M. Demers | M | 86 |
AutoGenomics, Inc.
AutoGenomics, Inc. Medical SpecialtiesHealth Technology AutoGenomics, Inc. engages in the design, development, manufacture, and marketing of an automated, microarray-based multiplexing diagnostic platform. The company was founded by Fareed Kureshy, Shailendra Singh, and Ramanath Vairavan in April 1999 and is headquartered in Carlsbad, CA. | - |
| Evelyn Lopez | F | - |
AutoGenomics, Inc.
AutoGenomics, Inc. Medical SpecialtiesHealth Technology AutoGenomics, Inc. engages in the design, development, manufacture, and marketing of an automated, microarray-based multiplexing diagnostic platform. The company was founded by Fareed Kureshy, Shailendra Singh, and Ramanath Vairavan in April 1999 and is headquartered in Carlsbad, CA. | 18 anni |
| Saeed Kureshy | M | - |
AutoGenomics, Inc.
AutoGenomics, Inc. Medical SpecialtiesHealth Technology AutoGenomics, Inc. engages in the design, development, manufacture, and marketing of an automated, microarray-based multiplexing diagnostic platform. The company was founded by Fareed Kureshy, Shailendra Singh, and Ramanath Vairavan in April 1999 and is headquartered in Carlsbad, CA. | 19 anni |
| Stephen D. Allison | M | 79 |
AutoGenomics, Inc.
AutoGenomics, Inc. Medical SpecialtiesHealth Technology AutoGenomics, Inc. engages in the design, development, manufacture, and marketing of an automated, microarray-based multiplexing diagnostic platform. The company was founded by Fareed Kureshy, Shailendra Singh, and Ramanath Vairavan in April 1999 and is headquartered in Carlsbad, CA. | 13 anni |
| Thomas Hennessey | M | - |
Hopewell Therapeutics, Inc.
Hopewell Therapeutics, Inc. BiotechnologyHealth Technology Hopewell Therapeutics, Inc. is a company that is focused on discovering, synthesizing, and developing tissue-targeted lipid nanoparticles (TTLNPs) to bring genomic medicines to patients. The company is based in Woburn, MA and was founded in 2018 by Qiaobing Xu. Hopewell is pursuing opportunities to redefine the non-viral delivery space for novel genomic medicines by designing systemically administered LNPs to specifically target extrahepatic tissues and cells throughout the body. The company has built a robust intellectual property portfolio with an expansive library of ionizable lipids and has established partnerships with several industry-leading companies. Hopewell is developing its own internal pipeline, initially targeting diseases of the lung, while concurrently exploring the potential of its TTLNP platform for patients with unmet needs in oncology, infectious diseases, rare genetic diseases, and neurological disorders. Louis Brenner has been the CEO of the company since 2022. | - |
Grafico relazionale
Relazione in diverse aziende
Relazioni precedenti
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| William Davidson | M | 73 |
AutoGenomics, Inc.
AutoGenomics, Inc. Medical SpecialtiesHealth Technology AutoGenomics, Inc. engages in the design, development, manufacture, and marketing of an automated, microarray-based multiplexing diagnostic platform. The company was founded by Fareed Kureshy, Shailendra Singh, and Ramanath Vairavan in April 1999 and is headquartered in Carlsbad, CA. | 6 anni |
| Donald E. Pogorzelski | M | 73 |
AutoGenomics, Inc.
AutoGenomics, Inc. Medical SpecialtiesHealth Technology AutoGenomics, Inc. engages in the design, development, manufacture, and marketing of an automated, microarray-based multiplexing diagnostic platform. The company was founded by Fareed Kureshy, Shailendra Singh, and Ramanath Vairavan in April 1999 and is headquartered in Carlsbad, CA. | - |
| Eugene J. Zurlo | M | 86 |
AutoGenomics, Inc.
AutoGenomics, Inc. Medical SpecialtiesHealth Technology AutoGenomics, Inc. engages in the design, development, manufacture, and marketing of an automated, microarray-based multiplexing diagnostic platform. The company was founded by Fareed Kureshy, Shailendra Singh, and Ramanath Vairavan in April 1999 and is headquartered in Carlsbad, CA. | - |
| John R. Zacamy | M | 75 |
AutoGenomics, Inc.
AutoGenomics, Inc. Medical SpecialtiesHealth Technology AutoGenomics, Inc. engages in the design, development, manufacture, and marketing of an automated, microarray-based multiplexing diagnostic platform. The company was founded by Fareed Kureshy, Shailendra Singh, and Ramanath Vairavan in April 1999 and is headquartered in Carlsbad, CA. | - |
| Joseph Sullivan | M | 81 |
AutoGenomics, Inc.
AutoGenomics, Inc. Medical SpecialtiesHealth Technology AutoGenomics, Inc. engages in the design, development, manufacture, and marketing of an automated, microarray-based multiplexing diagnostic platform. The company was founded by Fareed Kureshy, Shailendra Singh, and Ramanath Vairavan in April 1999 and is headquartered in Carlsbad, CA. | 6 anni |
| Tom R. Testman | M | 87 |
AutoGenomics, Inc.
AutoGenomics, Inc. Medical SpecialtiesHealth Technology AutoGenomics, Inc. engages in the design, development, manufacture, and marketing of an automated, microarray-based multiplexing diagnostic platform. The company was founded by Fareed Kureshy, Shailendra Singh, and Ramanath Vairavan in April 1999 and is headquartered in Carlsbad, CA. | 10 anni |
| Eric S. Kentor | M | 65 |
AutoGenomics, Inc.
AutoGenomics, Inc. Medical SpecialtiesHealth Technology AutoGenomics, Inc. engages in the design, development, manufacture, and marketing of an automated, microarray-based multiplexing diagnostic platform. The company was founded by Fareed Kureshy, Shailendra Singh, and Ramanath Vairavan in April 1999 and is headquartered in Carlsbad, CA. | 3 anni |
| Douglas Harrington | M | 71 |
AutoGenomics, Inc.
AutoGenomics, Inc. Medical SpecialtiesHealth Technology AutoGenomics, Inc. engages in the design, development, manufacture, and marketing of an automated, microarray-based multiplexing diagnostic platform. The company was founded by Fareed Kureshy, Shailendra Singh, and Ramanath Vairavan in April 1999 and is headquartered in Carlsbad, CA. | - |
| Randall Lunn | M | 73 |
AutoGenomics, Inc.
AutoGenomics, Inc. Medical SpecialtiesHealth Technology AutoGenomics, Inc. engages in the design, development, manufacture, and marketing of an automated, microarray-based multiplexing diagnostic platform. The company was founded by Fareed Kureshy, Shailendra Singh, and Ramanath Vairavan in April 1999 and is headquartered in Carlsbad, CA. | 11 anni |
| Joseph S. Coyne | M | 76 |
AutoGenomics, Inc.
AutoGenomics, Inc. Medical SpecialtiesHealth Technology AutoGenomics, Inc. engages in the design, development, manufacture, and marketing of an automated, microarray-based multiplexing diagnostic platform. The company was founded by Fareed Kureshy, Shailendra Singh, and Ramanath Vairavan in April 1999 and is headquartered in Carlsbad, CA. | - |
| Nanibhushan Dattagupta | M | 80 |
AutoGenomics, Inc.
AutoGenomics, Inc. Medical SpecialtiesHealth Technology AutoGenomics, Inc. engages in the design, development, manufacture, and marketing of an automated, microarray-based multiplexing diagnostic platform. The company was founded by Fareed Kureshy, Shailendra Singh, and Ramanath Vairavan in April 1999 and is headquartered in Carlsbad, CA. | - |
| Richard D. Hamill | M | - |
AutoGenomics, Inc.
AutoGenomics, Inc. Medical SpecialtiesHealth Technology AutoGenomics, Inc. engages in the design, development, manufacture, and marketing of an automated, microarray-based multiplexing diagnostic platform. The company was founded by Fareed Kureshy, Shailendra Singh, and Ramanath Vairavan in April 1999 and is headquartered in Carlsbad, CA. | 8 anni |
| Charles D. Birmingham | M | 73 |
AutoGenomics, Inc.
AutoGenomics, Inc. Medical SpecialtiesHealth Technology AutoGenomics, Inc. engages in the design, development, manufacture, and marketing of an automated, microarray-based multiplexing diagnostic platform. The company was founded by Fareed Kureshy, Shailendra Singh, and Ramanath Vairavan in April 1999 and is headquartered in Carlsbad, CA. | - |
| Patrick J. Dillon | M | 62 |
AutoGenomics, Inc.
AutoGenomics, Inc. Medical SpecialtiesHealth Technology AutoGenomics, Inc. engages in the design, development, manufacture, and marketing of an automated, microarray-based multiplexing diagnostic platform. The company was founded by Fareed Kureshy, Shailendra Singh, and Ramanath Vairavan in April 1999 and is headquartered in Carlsbad, CA. | - |
| Robert B. Cole | M | - |
AutoGenomics, Inc.
AutoGenomics, Inc. Medical SpecialtiesHealth Technology AutoGenomics, Inc. engages in the design, development, manufacture, and marketing of an automated, microarray-based multiplexing diagnostic platform. The company was founded by Fareed Kureshy, Shailendra Singh, and Ramanath Vairavan in April 1999 and is headquartered in Carlsbad, CA. | - |
| Dongmei Wang | F | - |
AutoGenomics, Inc.
AutoGenomics, Inc. Medical SpecialtiesHealth Technology AutoGenomics, Inc. engages in the design, development, manufacture, and marketing of an automated, microarray-based multiplexing diagnostic platform. The company was founded by Fareed Kureshy, Shailendra Singh, and Ramanath Vairavan in April 1999 and is headquartered in Carlsbad, CA. | 3 anni |
Statistiche
| Paese | Relazioni | % del totale |
|---|---|---|
| Stati Uniti | 36 | 100.00% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Thomas Hennessey
- Contatti personali
